Twist Bioscience Corporation (TWST)
USD 44.61
(-7.83%)
USD 44.61
(-7.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 354.18 Million USD | 15.41% |
| 2023 | 306.88 Million USD | -10.99% |
| 2022 | 333.25 Million USD | 62.59% |
| 2021 | 204.97 Million USD | 40.13% |
| 2020 | 146.27 Million USD | 26.31% |
| 2019 | 115.8 Million USD | 81.53% |
| 2018 | 63.79 Million USD | 41.05% |
| 2017 | 45.22 Million USD | 23.9% |
| 2016 | 36.5 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 75.93 Million USD | 6.75% |
| 2024 Q2 | 79.77 Million USD | 5.05% |
| 2024 Q3 | 79.26 Million USD | 55.69% |
| 2023 FY | 296.63 Million USD | -10.99% |
| 2023 Q4 | 71.13 Million USD | 0.78% |
| 2023 Q2 | 81.34 Million USD | 10.57% |
| 2023 Q1 | 73.56 Million USD | -12.18% |
| 2023 Q3 | 70.58 Million USD | -13.23% |
| 2022 Q3 | 90.53 Million USD | 6.22% |
| 2022 Q4 | 83.76 Million USD | -7.48% |
| 2022 FY | 333.25 Million USD | 62.59% |
| 2022 Q1 | 73.72 Million USD | 27.81% |
| 2022 Q2 | 85.22 Million USD | 15.6% |
| 2021 FY | 204.97 Million USD | 40.13% |
| 2021 Q4 | 57.68 Million USD | 6.2% |
| 2021 Q1 | 42.79 Million USD | 10.23% |
| 2021 Q2 | 50.18 Million USD | 17.26% |
| 2021 Q3 | 54.31 Million USD | 8.24% |
| 2020 Q2 | 37.81 Million USD | 3.04% |
| 2020 FY | 146.27 Million USD | 26.31% |
| 2020 Q1 | 36.7 Million USD | 5.11% |
| 2020 Q4 | 38.82 Million USD | 17.89% |
| 2020 Q3 | 32.93 Million USD | -12.92% |
| 2019 Q4 | 34.91 Million USD | 15.14% |
| 2019 FY | 115.8 Million USD | 81.53% |
| 2019 Q3 | 30.32 Million USD | 8.19% |
| 2019 Q2 | 28.03 Million USD | 24.41% |
| 2019 Q1 | 22.53 Million USD | 18.48% |
| 2018 Q1 | 13.56 Million USD | 2.31% |
| 2018 Q2 | 14.68 Million USD | 8.28% |
| 2018 FY | 63.79 Million USD | 41.05% |
| 2018 Q3 | 16.52 Million USD | 12.49% |
| 2018 Q4 | 19.01 Million USD | 15.09% |
| 2017 FY | 45.22 Million USD | 23.9% |
| 2017 Q3 | 11.05 Million USD | 0.0% |
| 2017 Q4 | 13.26 Million USD | 19.97% |
| 2016 FY | 36.5 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | -137.716% |
| Prenetics Global Limited | 60.73 Million USD | -483.141% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -2076.622% |
| CareDx, Inc | 277.76 Million USD | -27.509% |
| Exact Sciences Corporation | 2.06 Billion USD | 82.811% |
| Exagen Inc. | 52.29 Million USD | -577.299% |
| Inotiv, Inc. | 246.9 Million USD | -43.449% |
| Guardant Health, Inc. | 901.62 Million USD | 60.717% |
| Biodesix, Inc. | 77.41 Million USD | -357.485% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -8928.097% |
| Precipio, Inc. | 13.63 Million USD | -2497.008% |
| iSpecimen Inc. | 16.27 Million USD | -2075.918% |
| Natera, Inc. | 938.98 Million USD | 62.281% |
| Aspira Women's Health Inc. | 24.11 Million USD | -1368.773% |
| Standard BioTools Inc. | 113.48 Million USD | -212.083% |
| 23andMe Holding Co. | 420.73 Million USD | 15.818% |
| Castle Biosciences, Inc. | 242.78 Million USD | -45.883% |
| Personalis, Inc. | 128.14 Million USD | -176.392% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -220.452% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -2048.274% |
| OpGen, Inc. | 30.65 Million USD | -1055.263% |
| T2 Biosystems, Inc. | 41.49 Million USD | -753.569% |
| Myriad Genetics, Inc. | 600.1 Million USD | 40.98% |
| ICON Public Limited Company | 755.64 Million USD | 53.129% |
| NeoGenomics, Inc. | 341.25 Million USD | -3.788% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -2076.622% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 67.591% |
| RadNet, Inc. | 268.87 Million USD | -31.725% |
| MDxHealth SA | 71.25 Million USD | -397.053% |
| Psychemedics Corporation | 11.33 Million USD | -3024.934% |
| Illumina, Inc. | 3.81 Billion USD | 90.711% |
| Check-Cap Ltd. | 19.28 Million USD | -1736.366% |
| DarioHealth Corp. | 62.17 Million USD | -469.669% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -106.031% |
| Sera Prognostics, Inc. | 39.91 Million USD | -787.291% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -3266.495% |
| OPKO Health, Inc. | 574.68 Million USD | 38.37% |
| Medpace Holdings, Inc. | 187.68 Million USD | -88.715% |
| Neogen Corporation | 405.23 Million USD | 12.599% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -2924.904% |
| Prenetics Global Limited | 60.73 Million USD | -483.141% |
| Mainz Biomed B.V. | 27.15 Million USD | -1204.322% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -3940.917% |
| Trinity Biotech plc | 46.49 Million USD | -661.759% |
| Neuronetics, Inc. | 82.25 Million USD | -330.567% |
| Sotera Health Company | 300.46 Million USD | -17.877% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -3940.917% |